Article -> Article Details
| Title | India Medical Gas Market Size and Report by 2033 | Get a Free Sample Report |
|---|---|
| Category | Sciences --> Medical |
| Meta Keywords | india medical gas market |
| Owner | SAKSHI BAHANDARI |
| Description | |
| As indicated in the latest market research report published by IMARC Group, titled "India Medical Gas Market Size, Share, Trends and Forecast by Gas Type, Application, End User, and Region, 2025-2033" this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential The India medical gas
market size reached USD 715.50 Million in 2024. Looking
forward, IMARC Group expects the market to reach USD 1,656.70 Million
by 2033, reflecting India's rapid expansion in healthcare infrastructure,
medical device adoption, and home healthcare services driving unprecedented
demand for essential medical gases across hospitals, clinics, and residential
settings. Latest Market Trends India's medical gas market is experiencing transformative
growth driven by rapid healthcare infrastructure expansion, evolving consumer
health patterns, technological innovation, and strategic government
initiatives. The market is reshaping across multiple dimensions that are
fundamentally changing how medical gases are produced, distributed, and
utilized across the healthcare ecosystem. Healthcare Infrastructure Expansion and Medical Oxygen
Self-Sufficiency Revolution: India is undergoing dramatic healthcare
infrastructure expansion that directly increases medical gas consumption and
creates supply-chain imperatives. The Government of India's Pradhan Mantri
Atmanirbhar Swasth Bharat Yojana (PMASBY) has invested INR 64,180 crore in
healthcare infrastructure enhancement, creating 17,788 rural and 11,024 urban
Health and Wellness Centers that require consistent medical gas supplies. The
COVID-19 pandemic exposed critical oxygen supply vulnerabilities—in April 2020,
India had only 62,458 oxygen-supported beds, but by February 2024, this had
surged to 515,345 beds—a 725% increase that demonstrates hospital system
transformation. More significantly, India's Health Ministry commissioned 162
PSA (Pressure Swing Adsorption) oxygen generation plants under PM-ABHIM,
directly increasing oxygen self-sufficiency across over 20 states. This
decentralized oxygen generation infrastructure ensures consistent supply to
rural and remote healthcare facilities, creating market expansion opportunities
as hospitals and clinics upgrade oxygen pipeline infrastructure. Respiratory Disease Burden and Chronic Disease Growth:
Chronic respiratory diseases are creating persistent, structural demand for
medical gases. An estimated 7% of individuals over 30 years of age suffer from
COPD (Chronic Obstructive Pulmonary Disease), one of India's leading chronic
respiratory illnesses, with incidence rising alongside air pollution, smoking
prevalence, and changing lifestyles. Asthma prevalence continues to increase in
urban centers due to environmental pollution and indoor air quality
deterioration. Cardiovascular disease incidence is also rising, with many
cardiovascular conditions requiring oxygen therapy and other medical gas
interventions. This disease burden creates continuous demand for oxygen therapy
across various healthcare environments—hospitals, clinics, and increasingly,
home-based care settings. Air pollution levels in major Indian cities
consistently exceed WHO standards, with Delhi and other metros experiencing
hazardous air quality during winter months, directly correlating with increased
respiratory admissions and oxygen demand. Request Free Sample Report: https://www.imarcgroup.com/india-medical-gas-market/requestsample Market Scope and Growth Factors India's medical gas market scope is expanding dramatically
as multiple interconnected factors create an exceptional growth environment.
The market is benefiting from structural shifts in healthcare delivery,
strategic government positioning, and ecosystem-wide infrastructure
modernization. Government Healthcare Investment and Policy Framework:
The Indian government has demonstrated unprecedented commitment to healthcare
infrastructure development. The 2021-22 Union Budget invested INR 2,23,846
crore in health and well-being—a 137% increase from the previous fiscal year.
The Pradhan Mantri Atmanirbhar Swasth Bharat Yojana (PMASBY) specifically
allocated INR 64,180 crore to enhance healthcare infrastructure at primary,
secondary, and tertiary levels. The Ayushman Bharat scheme has created universal
healthcare access for over 550 million beneficiaries, directly increasing
hospital admissions and medical gas consumption. These government investments
create persistent demand for medical gas supply systems, pipeline
infrastructure, and backup oxygen generation capacity. The government's focus
on Health and Wellness Centers across rural and urban areas ensures that
medical services reach previously underserved populations, creating
decentralized demand for medical gas supplies. Medical Device Manufacturing Expansion and PLI Scheme:
The Production-Linked Incentive (PLI) Scheme for medical devices provides
substantial financial rewards to both domestic and international manufacturers
expanding Indian production. This scheme has catalyzed establishment of new
medical device manufacturing facilities across India, with significant
concentration in northern regions. Each manufacturing facility expansion
creates upstream demand for medical gases used in device testing, calibration,
and production processes. Additionally, increased device production directly
drives end-user demand for medical gases as hospitals and clinics deploy new
ventilators, anesthesia systems, diagnostic equipment, and monitoring devices. Explore the Full Report with Charts, Table of Contents,
and List of Figures: https://www.imarcgroup.com/india-medical-gas-market Comprehensive Market Report Highlights & Segmentation
Analysis Segmentation by Gas Type: Pure Gas:
Gas Mixtures:
Segmentation by Application:
Segmentation by End User:
Segmentation by Region:
Recent News and Developments
Competitor Landscape The report offers an in-depth examination of the competitive
landscape. It includes a thorough competitive analysis encompassing market
structure, key player positioning, leading strategies for success, a
competitive dashboard, and a company evaluation quadrant. The competitive
landscape encompasses multinational industrial gas corporations (Linde, Air
Liquide, Praxair), established Indian manufacturers (Gas India Limited, Bharat
Medical Gas Limited), specialized medical gas providers, equipment
manufacturers, and emerging startups focusing on innovative delivery systems
and telemedicine-integrated gas monitoring. Key strategies include geographic
expansion through regional manufacturing facilities, technology partnerships
with device manufacturers, investments in centralized pipeline systems and
safety equipment, development of portable oxygen concentrators and home
healthcare solutions, and integration of digital monitoring and predictive
maintenance capabilities. Companies are also focusing on sustainability
initiatives, cost-effective solutions for rural healthcare settings, and
adherence to stringent regulatory standards. Discuss Your Needs with Our Analyst – Get Customized
Report Now: https://www.imarcgroup.com/request?type=report&id=29736&flag=E Note: Should you require specific information not included in the
current report, we are pleased to offer customization options to meet your
needs. About Us IMARC Group is a leading market research company that offers
management strategy and market research worldwide. We partner with clients in
all sectors and regions to identify their highest-value opportunities, address
their most critical challenges, and transform their businesses. IMARC's information products include major market,
scientific, economic, and technological developments for business leaders in
pharmaceutical, industrial, and high-technology organizations. Market forecasts
and industry analysis for biotechnology, advanced materials, pharmaceuticals,
food and beverage, travel and tourism, nanotechnology, and novel processing
methods are at the top of the company's expertise. Contact Us IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: Sales@imarcgroup.com Tel No: (D) +91 120 433 0800 Americas: +1-201-971-6302 | Africa and Europe: +44-702-409-7331 | |
